Abstract:Human &Experimental Toxicology, Volume 43, Issue , January-December 2024. IntroductionAbnormal activation of hypertrophic scar fibroblasts (HSF) plays an important role in the excessive fibrosis of hypertrophic scars (HS). However, the regulatory mechanism of HSF abnormal activation is not fully unclear. Early studies had shown that M2 macrophages were increased during scar formation. The aim of this study was to investigate the mechanism of M2 macrophage-derived exosomes (M2-EXOs) mediating HSF abnormal activation.MethodsThe blood samples of 20 normal people and 20 HS patients were collected from Xi'an Hospital of Traditional Chinese Medicine, and the level of M2 macrophages in the blood was measured by flow cytometry. Subsequently, HSFs were co-cultured with M2-THP-1 for 48 h to analyze the effect of M2 macrophages on the function of HSFs in vitro. HSFs were treated with exogenous chemokine (C-X-C motif) ligand 2 (CXCL2) or anti-CXCL2 to analyze the effect of CXCL2 on HSFs function and autophagy. HSFs were treated with exogenous CXCL2 and/or anti-CXCR7, and CXCL2 and/or 3MA to explore the molecular mechanism of CXCL2-mediated HS. Finally, a mouse HS model was constructed, and the effect of M2-Exos on the growth of HS was explored by subcutaneous injection of CXCL2 or M2-Exos in the scar site in vivo.ResultsWe found that the proportion of M2 macrophages in the blood of HS patients increased. CXCL2-rich M2-EXOs promoted the abnormal proliferation, migration, and collagen deposition of HSFs in vitro. CXCL2 increased the level of p-mTOR in HSF and promoted the expression of autophagy proteins LC3II/I and Atg5 in vitro. Further results showed that CXCL2 activated autophagy through CXCR7/PI3K/mTOR signal transduction, thereby promoting collagen deposition and fibrosis in vitro. Autophagy inhibitor 3-MA reversed the effect of CXCL2 on HSFs in vitro. In addition, in the HS mouse model, after treatment with M2-EXOs or CXCL2 in vivo, the scar recovery time was significantly prolonged and the scar damage was aggravated.DiscussionThese results suggest that the CXCL2/CXCR7/mTOR pathway may be a promising target for the treatment of HS. Abnormal activation of hypertrophic scar fibroblasts (HSFs) plays an important role in the excessive fibrosis of hypertrophic scars (HS). However, the regulatory mechanism of HSFs abnormal activation is not fully unclear. Early studies had shown that M2 macrophages were increased during scar formation. The aim of this study was to investigate the mechanism of M2 macrophage-derived exosomes (M2-EXOs) mediating HSFs abnormal activation. Here, we analyzed the proportion of M2 macrophages in total macrophages in the HS patient's blood, and we found that the proportion of M2 macrophages were elevated in the blood of HS patients. We found that C-X-C motif chemokine 2 (CXCL2)-rich M2-EXOs promoted abnormal proliferation, migration, and collagen deposition in HSFs in vitro. CXCL2 increased the phosphorylation level of mTOR protein and promoted the expression levels of autophagy related proteins LC3II/I and Atg5 in HSF in vitro. CXCL2 activated autophagy through chemokine (C-X-C motif) receptor 7(CXCR7)/PI3K/mTOR signal transduction, and promoted collagen deposition and fibrosis in vitro. The autophagy inhibitor 3-Methyladenine (3-MA) reversed the effect of CXCL2 on HSFs in vitro. Meanwhile, in the HS mouse model, the scar recovery time was significantly prolonged and the scar injury was aggravated after treatment with M2-EXOs or CXCL2 in vivo. These results suggest that the CXCL2/CXCR7/mTOR pathway may be a promising target for the treatment of HS.

SHH induces macrophage oxidative phosphorylation and efferocytosis to promote scar formation

Adenovirus-mediated METH1 gene expression inhibits hypertrophic scarring in a rabbit ear model.

Direct And Indirect Roles Of Macrophages In Hypertrophic Scar Formation

The role of macrophages in the formation of hypertrophic scars and keloids

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

Insufficient SIRT1 in macrophages promotes oxidative stress and inflammation during scarring

The Clinical Dynamic Changes Of Macrophage Phenotype And Function In Different Stages Of Human Wound Healing And Hypertrophic Scar Formation

Human-Specific Gene Chrfam7a Mediates M2 Macrophage Polarization Via The Notch Pathway To Ameliorate Hypertrophic Scar Formation

IL-17 Promotes Scar Formation by Inducing Macrophage Infiltration.

Fibroblasts and endothelial cells interplay drives hypertrophic scar formation: Insights from in vitro and in vivo models

Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation

Emodin alleviates hypertrophic scar formation by suppressing macrophage polarization and inhibiting the Notch and TGF-β pathways in macrophages

The regulatory role of the apelin/APJ axis in scarring: Identification of upstream and downstream mechanisms

Notch signal deficiency alleviates hypertrophic scar formation after wound healing through the inhibition of inflammation.

Exosomes derived from M2 macrophages promote fibroblast autophagy to contribute to hypertrophic scar formation via CXCL2/CXCR7/mTOR pathway

Macrophage Polarization in Skin Wound Healing: Progress in Biology and Therapeutics

Adipose-Derived Mesenchymal Stem Cells Alleviate Hypertrophic Scar by Inhibiting Bioactivity and Inducing Apoptosis in Hypertrophic Scar Fibroblasts

Shikonin promotes hypertrophic scar repair by autophagy of hypertrophic scar-derived fibroblasts

Shh regulates M2 microglial polarization and fibrotic scar formation after ischemic stroke

Triggering of P38 MAPK and JNK Signaling is Important for Oleanolic Acid-Induced Apoptosis Via the Mitochondrial Death Pathway in Hypertrophic Scar Fibroblasts.

Wild-type p53-modulated autophagy and autophagic fibroblast apoptosis inhibit hypertrophic scar formation